TABLE 2.
Patients with vertigo versus healthy controls for each microstate class.
| Parameter | Micostate | Vertigo | HC | p-Value |
| Mean duration (ms) | Class A | 70.57 ± 16.02 | 63.62 ± 8.39 | 0.0129 |
| Class B | 65.52 ± 14.03 | 63.64 ± 10.10 | 0.4764 | |
| Class C | 62.51 ± 24.02 | 67.20 ± 16.75 | 0.2954 | |
| Class D | 69.62 ± 21.68 | 62.88 ± 22.19 | 0.1614 | |
| Time coverage (%) | Class A | 28.53 ± 11.46 | 25.19 ± 8.21 | 0.1229 |
| Class B | 25.02 ± 8.95 | 25.22 ± 7.37 | 0.9094 | |
| Class C | 18.14 ± 12.32 | 27.22 ± 11.60 | 0.0007 | |
| Class D | 28.31 ± 13.42 | 22.37 ± 12.70 | 0.0389 | |
| Occurrence | Class A | 4.03 ± 1.06 | 3.94 ± 0.97 | 0.6905 |
| Class B | 3.82 ± 0.85 | 3.97 ± 0.81 | 0.4029 | |
| Class C | 2.74 ± 1.17 | 4.00 ± 1.15 | <0.0001 | |
| Class D | 4.01 ± 1.28 | 3.42 ± 1.18 | 0.0275 |
p-Values refer to unpaired t-test p-value for each parameter separately between patients with vertigo and healthy controls. Statistically significant differences are in bold.